These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2599653)
21. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa. Bayer AS; Kim KS Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342 [TBL] [Abstract][Full Text] [Related]
22. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model. Bamberger DM; Peterson LR; Gerding DN; Moody JA; Fasching CE J Antimicrob Chemother; 1986 Jul; 18(1):51-63. PubMed ID: 3093445 [TBL] [Abstract][Full Text] [Related]
23. [Combined chemotherapy of experimental infection in neutropenia]. Viadro MM; Ivanitskaia LP; Samoĭlova LN; Kudinova MK; Bodunkova LE Antibiot Khimioter; 1989 May; 34(5):378-82. PubMed ID: 2662929 [TBL] [Abstract][Full Text] [Related]
24. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients. Johnson PR; Liu Yin JA; Tooth JA J Antimicrob Chemother; 1992 Aug; 30(2):203-14. PubMed ID: 1399929 [TBL] [Abstract][Full Text] [Related]
25. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. Fichtenbaum CJ; Smith MJ Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451 [TBL] [Abstract][Full Text] [Related]
26. A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients. Hyatt DS; Rogers TR; McCarthy DM; Samson DS J Antimicrob Chemother; 1991 Aug; 28(2):324-6. PubMed ID: 1778867 [No Abstract] [Full Text] [Related]
27. Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients. Philpott-Howard JN; Barker KF; Wade JJ; Kaczmarski RS; Smedley JC; Mufti GJ J Antimicrob Chemother; 1990 Dec; 26 Suppl F():89-99. PubMed ID: 2292549 [TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model. Peterson LR; Moody JA; Fasching CE; Gerding DN Diagn Microbiol Infect Dis; 1987 Jun; 7(2):127-36. PubMed ID: 3115671 [TBL] [Abstract][Full Text] [Related]
29. Synergistic activity of apalcillin and gentamicin in a combination therapy in experimental Pseudomonas bacteraemia of neutropenic mice. Fu KP; Hetzel N; Hung PP; Gregory FJ J Antimicrob Chemother; 1986 Apr; 17(4):499-503. PubMed ID: 3710958 [TBL] [Abstract][Full Text] [Related]
30. Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. Follath F; Bindschedler M; Wenk M; Frei R; Stalder H; Reber H Eur J Clin Microbiol; 1986 Apr; 5(2):236-40. PubMed ID: 2941289 [TBL] [Abstract][Full Text] [Related]
31. Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa. Norden CW; Shaffer MA Antimicrob Agents Chemother; 1982 Jan; 21(1):62-5. PubMed ID: 6805423 [TBL] [Abstract][Full Text] [Related]
32. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside. Baruchel A; Hartmann O; Andremont A; Tancrède C J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the antibacterial activity of azlocillin and ticarcillin in vitro and in irradiated neutropenic mice. van der Voet GB; Mattie H; van Furth R J Antimicrob Chemother; 1985 Nov; 16(5):605-13. PubMed ID: 3935638 [TBL] [Abstract][Full Text] [Related]
34. In vitro models in the study of antibiotic therapy of infections in neutropenic patients. Zinner SH; Blaser J Am J Med; 1986 May; 80(5C):40-4. PubMed ID: 3717188 [TBL] [Abstract][Full Text] [Related]
35. Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. Chadwick EG; Shulman ST; Yogev R J Infect Dis; 1986 Oct; 154(4):670-5. PubMed ID: 3528320 [TBL] [Abstract][Full Text] [Related]
36. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa. Wu YL; Scott EM; Po AL; Tariq VN J Antimicrob Chemother; 1999 Sep; 44(3):389-92. PubMed ID: 10511408 [TBL] [Abstract][Full Text] [Related]
37. [Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa]. Liu MT; Sheng MY; Zhang Y; Li Y Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1427-31. PubMed ID: 21756818 [TBL] [Abstract][Full Text] [Related]
38. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429 [TBL] [Abstract][Full Text] [Related]
39. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Peterson LR; Gerding DN; Moody JA; Fasching CE Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087 [TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients. Ebenezer S; Lalitha MK; Jesudason MV; Chandy M Indian J Cancer; 1994 Mar; 31(1):23-6. PubMed ID: 8063332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]